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Summary 
The cell wall peptidoglycan (PG) of Burkholderia cenocepacia, an opportunistic 
pathogen, has not been characterized. However, the B. cenocepacia genome contains 
homologues of genes encoding PG biosynthetic functions in other bacteria. PG 
biosynthesis involves the formation of the undecaprenyl-pyrophosphate-linked N-acetyl 
glucosamine-N-acetyl muramic acid-MurNAc-pentapeptide, known as lipid II, which is 
built on the cytosolic face of the cell membrane. Lipid II is then translocated across the 
membrane and its glycopeptide moiety becomes incorporated into the growing cell wall 
mesh; this translocation step is critical for PG synthesis. We have investigated candidate 
flippase homologs of the MurJ family in B. cenocepacia. Our results show that 
BCAL2764, herein referred to as murJBc, is indispensable for viability. Viable B. 
cenocepacia could only be obtained through a conditional mutagenesis strategy by 
placing murJBc under the control of a rhamnose-inducible promoter. Under rhamnose 
depletion the conditional strain stopped growing and individual cells displayed 
morphological abnormalities consistent with a defect in PG synthesis. Bacterial cells 
unable to express MurJBc underwent cell lysis, while partial MurJBc depletion sensitized 
the mutant to the action of β-lactam antibiotics. Depletion of MurJBc caused accumulation 
of PG precursors consistent with the notion that this protein plays a role in lipid II 
flipping to the periplasmic compartment. Reciprocal complementation experiments of 
conditional murJ mutants in B. cenocepacia and Escherichia coli with plasmids 
expressing MurJ from each strain indicated that MurJBc and MurJEc are functional 
homologs. Together, our results are consistent with the notion that MurJBc is a PG lipid II 
flippase in B. cenocepacia.  
 
Keywords: flippase, cell wall, undecaprenylphosphate, essential gene, cystic fibrosis.  
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Introduction 
Burkholderia cenocepacia, a metabolically diverse Gram-negative β-proteobacterium, is 
widespread in the rhizosphere. This bacterium often causes opportunistic, chronic lung 
infections in patients with cystic fibrosis (Vandamme, et al. 1997). Environmental bacteria are 
usually exposed to dramatic changes in growth conditions, which include variations in 
temperature, pH, concentration of nutrients and salinity, exposure to toxic metals and biocides, 
and encounters with predator and host organisms. We speculate that the ability of these 
bacteria to adapt and withstand these changes relies in part on the synthesis and remodelling of 
the cell wall peptidoglycan (PG), which is a key for cell division, bacterial shape, and survival 
under high internal turgor pressure. PG surrounds bacterial cells forming a mesh-like 
glycopeptide polymer made of repeating units of N-acetyl glucosamine (GlcNAc) and N-acetyl 
muramic acid (MurNAc). The carboxy group of the N-acetyl muramic acid residues is substituted 
by a pentapeptide that consists of L-alanine, L-glutamic acid, meso-diaminopimelic acid (or L-
lysine) and D-alanyl-D-alanine. The neighboring glycan chains are cross-linked by peptide 
linkages, resulting in rigid mesh-like macromolecular structure (van Heijenoort 2001). 
 To our knowledge, the biosynthesis of PG in the Burkholderia genus has not been studied. 
However, the B. cenocepacia genome contains homologues of the genes encoding all the 
enzymes required for the synthesis of PG precursors in other bacteria, suggesting the PG 
biosynthesis pathway is conserved. PG biosynthesis starts in the cytoplasm with the synthesis 
of the UDP-MurNAc-pentapeptide, which is catalyzed by the Mur ligases (Barreteau, et al. 2008) 
MurC (BCAL3641), MurD (BCAL3464), MurE (BCAL3467), and MurF (BCAL3466). This 
molecule is the substrate of the membrane protein MraY (BCAL3465) that catalyzes the 
formation of a phosphoanhydride bond with the lipid carrier, undecaprenyl phosphate (Und-P), 
and gives rise to Und-PP-MurNAc-pentapeptide also known as lipid I. The GlcNAc moiety from 
UDP-GlcNAc is transferred to lipid I, resulting in lipid II, a reaction catalyzed by the inner 
membrane-associated transferase MurG (BCAL3462) (Bouhss, et al. 2008). Lipid II is 
translocated across the cytoplasmic membrane to incorporate the PG subunits into the growing 
cell wall mesh. At the periplasmic side of the inner membrane, various penicillin-binding proteins 
catalyze the maturation of the growing peptidoglycan chain. Glycosyltransferases assemble lipid 
II to the existing peptidoglycan releasing Und-PP, which is recycled by an as yet unclear 
mechanism (Valvano 2008). The peptide chains are cross-linked by transpeptidases and 
terminal D-Ala is removed from the pentapeptide by D-D-carboxypeptidases (van Dam, et al. 
2007).  
 The transport of lipid II across the inner membrane is a key step in the synthesis of PG, but 
its mechanism is not completely elucidated. Studies using a fluorescence lipid II analog have 
revealed that the transbilayer movement of lipid II is independent of ATP hydrolysis or proton 
motive force, but it appears to be coupled to transglycosylation activity on the periplasmic side 
of the inner membrane (van Dam, et al. 2007). The Escherichia coli MurJ (Ruiz 2008), also 
known as MviN (Inoue, et al. 2008), is an integral membrane protein with multiple predicted 
transmembrane helices that belongs to the multi-antimicrobial extrusion-like superfamily. 
Members of this family include proteins like Wzx, which are implicated in the membrane flipping 
of lipid-linked oligosaccharide and polysaccharide precursors of lipopolysaccharide O-antigen 
and capsules (Islam and Lam 2013, Valvano and Hanuszkiewicz 2012). Studies in E. coli 
demonstrated that MviN is essential for viability. Cells from conditional mutants at non-
permissive conditions burst and accumulate lipid II (Inoue, et al. 2008, Ruiz 2008), suggesting 
this protein is involved in PG biosynthesis and functions as the lipid II flippase, being renamed 
MurJ (Ruiz 2008). Other studies have shown that MurJ (MviN) is essential in Burkholderia 
pseudomallei (Ling, et al. 2006) and Sinorhizobium meliloti (Rudnick, et al. 2001). In contrast, 
the simultaneous inactivation of four murJ homologues in Bacillus subtilis did not compromise 
bacterial viability, casting doubts on the functional assignment of this protein as a flippase (Fay 
and Dworkin 2009). In E. coli, other membrane proteins such as RodA and FtsW have also 
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been proposed to function as lipid II flippases (Ehlert and Holtje 1996, Mohammadi, et al. 2011). 
RodA is required for the synthesis of lateral PG while FtsW is involved in septal PG synthesis 
(Henriques, et al. 1998, Ikeda, et al. 1989, Ishino, et al. 1989, Ishino, et al. 1986, Khattar, et al. 
1994, Mercer and Weiss 2002, Tamaki, et al. 1980). A biochemical study using E. coli 
membrane vesicles demonstrated that transport of lipid II requires FtsW, but not MurJ, to 
mediate the transbilayer movement of lipid II in model membranes (Mohammadi, et al. 2011). 
However, this study did not rule out nonspecific flipping, a common occurrence in isolated 
vesicles and reconstituted in vitro systems (Kol, et al. 2001, Kol, et al. 2003). More recently, a 
three-dimensional model of the E. coli MurJ, together with topological studies and functional 
analyses of specific charged residues, strongly suggest that MurJ is a member of a large family 
of flippase proteins involved in O-antigen and capsule biosynthesis (Butler, et al. 2013).  
 In this study, we investigated candidate homologs of the MurJ (MviN) family in B. 
cenocepacia. We show that BCAL2764, herein designated murJBc, encodes a membrane 
protein that is indispensable for the viability of B. cenocepacia and also required for PG 
synthesis, while the other flippase homologues were not required for bacterial survival under 
laboratory conditions. Furthermore, MurJBc shared predicted structural features with its E. coli 
counterpart, and complementation experiments of conditional murJ mutants in B. cenocepacia 
and E. coli with plasmids expressing MurJ from each strain indicated that MurJBc and MurJEc are 
functional homologues.  
 
Results and Discussion 
 
B. cenocepacia murJ is an essential gene and a functional homologue of the E. coli murJ 
The initial aim of this study was to identify and elucidate the function of predicted flippases in B. 
cenocepacia. The annotated genome of B. cenocepacia J2315 was manually inspected for 
genes encoding proteins with 12 or more transmembrane helices, which were further examined 
by HHPRED using the Bioinformatics Toolkit from the Max-Planck Institute for Developmental 
Biology (http://toolkit.tuebingen.mpg.de/hhpred (Remmert, et al. 2011)) to identify hypothetical 
proteins with predicted flippase function based on homologies with domains commonly found in 
these proteins (MVIN, RfbX and Rft1 domains). This analysis identified the following genes: 
BCAL1907, BCAL2764 (herein designated murJBc, see below), and BCAL3114 in chromosome 
1; BCAM0204 and BCAM1007 in chromosome 2. No flippase homologues were noted in 
chromosome 3 genes. The gene context was also taken into account. BCAL1907 is part of a 
potential two-gene operon that includes BCAL1906, a predicted glycosyltransferase. murJBc is 
also part of a potential two-gene operon including BCAL2763, encoding a protein of unknown 
function. BCAL3114 was previously identified as wzx and is located on a transcriptional region 
immediately adjacent to the O-antigen gene cluster (Ortega, et al. 2005). Deletion of this gene 
does not affect O-antigen production in B. cenocepacia K56-2 (X. Ortega and M. A. Valvano, 
unpublished) since the O-antigen in this strain is exported by an ABC transporter encoded by 
wzt and wzm, both of which are located within the O-antigen gene cluster (Ortega, et al. 2005). 
BCAM0204 and BCAM1007 are part of the capsule polysaccharide cluster. Therefore, 
BCAL3114, BCAM0204, and BCAM1007 were not investigated further. B. cenocepacia has 
RodA and FtsW homologues (BCAL0478 and BCAL3463, respectively), which were also not 
investigated in this study.  
 To elucidate the possible function of BCAL1907 and murJBc we constructed unmarked 
deletion mutants as described in Materials and Methods. Whereas BCAL1907 was readily 
deleted without any apparent functional consequences to the bacterial cells, attempts to delete 
murJBc were consistently unsuccessful, as colonies carrying the deleted gene were never 
obtained. We suspected from these results that murJBc could be essential for B. cenocepacia 
viability. Therefore, we constructed a conditional mutant derivative of strain K56-2 by placing 
murJBc under the control of the rhamnose-inducible promoter (Prha). The resulting Prha::murJBc 
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strain (YFM1, Table 1) grew on solid medium in the presence of rhamnose (permissive 
condition), but failed to grow in the presence of glucose (non-permissive condition), as expected 
for a mutant with an essential gene under the control of Prha (Fig. 1A). Loss of viability in the 
absence of rhamnose was comparable to that found with the positive control strain XOA11, 
which has the essential gene arnT gene under the control of rhamnose (Prha::arnT) (Ortega, et 
al. 2007) (Fig. 1A). In contrast, the negative control strain XOA10 (Prha::BCAL1928) grew at the 
same rate with either rhamnose or glucose, as expected (Ortega, et al. 2007). Growth without 
added rhamnose was restored upon complementation of the Prha::murJBc conditional mutant by 
introduction of the replicative plasmid pDA12 expressing murJBc from a constitutive promoter 
(Fig. 1B). This confirmed that the growth defect was due to lack of murJBc expression and 
demonstrated that this gene encodes an essential function supporting bacterial viability.  
 We also assessed whether murJBc is functionally analogous to its E. coli orthologue. For 
these experiments we employed the E. coli strain NR1152, in which murJEc expression is under 
the control of the arabinose inducible promoter (Para::murJEc) (Ruiz 2008). Introduction of either 
the constitutive pDA12 or IPTG-inducible pEXT21 plasmids encoding murJBc into NR1152 
supported growth of this strain in the absence of arabinose, while the strain containing the 
empty vectors was nonviable (Fig. 1C). In the converse experiment, pDA12-murJEc was able to 
support viability of the strain carrying the Prha::murJBc construct (Fig. 1B). Together, these 
reciprocal complementation experiments demonstrated that the MurJ proteins of B. cenocepacia 
and E. coli are functionally interchangeable.  
 
Suppression of murJBc expression causes growth arrest, dramatic morphological changes, and 
cell lysis  
To better characterize the phenotype of the Prha::murJBc strain under non-permissive conditions 
we performed rhamnose depletion experiments in liquid medium (Ortega, et al. 2007). Fig. 2 
shows that after serial passage in medium with glucose, the turbidity of the Prha::murJBc strain 
culture rapidly reached a plateau compared to wild type strain and strain Prha::murJBc grown in 
the presence of rhamnose. Bacterial cells at 6-h post-depletion were examined for 
morphological changes by phase contrast microscopy. The majority of the Prha::murJBc cells 
appeared swollen, forming blebs, and also many cells had bursted forming "ghosts" (Fig. 3). 
Ultrastructural analysis by transmission electron microscopy revealed that cells had extremely 
irregular shapes, suggesting a dramatic defect in the rigidity of cell wall (Fig. 4). Using 
fluorescent microscopy and the Live/Dead kit we noticed that under rhamnose depletion 
bacterial cells became permeable to propidium iodide (Fig. 5). Also, red fluorescent mesh-like 
aggregates appeared suggesting binding of propidium iodide to released DNA upon cell lysis 
(Fig. 5). None of these changes in morphology or viability were apparent in Prha::murJBc cells 
that were not subjected to rhamnose depletion. Together, these results demonstrate that under 
non-permissive conditions Prha::murJBc bacteria were not only unable to grow, but also lost their 
normal shape, becoming osmotically fragile and bursting, which suggests a major defect in cell 
wall PG synthesis. 
 More conclusive evidence of cell lysis was obtained by examining leakage of intracellular 
components into the culture supernatants of Prha::murJBc cells placed under permissive and non-
permissive conditions. The results show that the supernatant from bacteria exposed to the non-
permissive condition has much more protein content than that of control cells (Fig. 6A). An 
immunoblot of the same gel using anti-RNA polymerase α-subunit antibody showed the leakage 
of this large protein into the supernatant (Fig. 6B). RNA polymerase is normally localized in the 
cytoplasmic compartment and cannot be released by active secretion in cells containing an 
intact cell envelope. This experiment confirms the supernatant of cells under non-permissive 
conditions contains released cytoplasmic content, supporting the conclusion that cells unable to 
express murJBc undergo cell lysis. 
 
	   5	  
Partial suppression of murJBc expression sensitizes cells to the action of β-lactam antibiotics 
We reasoned that if MurJBc functions in PG synthesis, bacterial growth of the conditional mutant 
under limiting amounts of rhamnose would be further reduced in the presence of cell wall-acting 
antibiotics. We used ceftazidime and imipenem for these experiments. Ceftazidime is a 
semisynthetic aminothiazolyl cephalosporin that inhibits penicillin-binding proteins, mainly 
penicillin-binding protein-3, and induces rapid cell lysis (Hayes and Orr 1983). Imipenem is a 
carbapenem antibiotic that like all other β-lactams, inhibits bacterial cell wall synthesis by 
binding to and inactivating penicillin binding proteins (Neu 1983) and also induces formation of 
spherical cells and subsequent cell lysis (Rodloff, et al. 2006). Bacteria were grown in either 
0.2% or 0.05% rhamnose. The high-rhamnose concentration is the normal inducing 
concentration for optimal gene expression, as empirically determined by the absence of any 
growth and morphology phenotypes, as described above. The lower concentration was selected 
to reach a state of partial depletion. At this concentration, the growth rate of the conditional 
mutant was not affected, as minimal amounts of rhamnose can induce the expression of 
MurJBc and rescue the mutant from cell death (Supplementary Fig. S1). However, under this 
minimal amount of rhamnose, defects in peptidoglycan start to appear which are still not enough 
to compromise viability. Under the rhamnose-rich concentration, Prha::murJBc had the same MIC 
values for ceftazidime and imipenem as the XOA10 (Prha::BCAL1928) control strain (Table III). 
However, the Prha::murJBc bacteria grown under the rhamnose-limiting condition had 6-fold and 
more than 32-fold decrease in the MIC to ceftazidime and imipenem, respectively. In contrast, 
the MIC value for chloramphenicol, a non cell wall acting antibiotic, did not change under the 
same conditions (Table III). In liquid growth experiments, a pronounced killing effect of 
ceftazidime and imipenem was also observed in cells grown at the rhamnose-limiting condition 
(Supplementary Fig. S1), while growth rate was comparable under rhamnose-rich and -limiting 
concentrations in absence of the antibiotics. Furthermore, growth rate did not vary in the 
presence of chloramphenicol (Supplementary Fig. S1). We conclude from these experiments 
that conditions leading to murJBc reduced expression result in higher bacterial susceptibility to 
cell wall acting antibiotics, supporting the notion of a defect in PG synthesis. 
 
Depletion of murJBc causes accumulation of [3H]-DAP 
The E. coli murJ has been proposed to encode the lipid II flippase required for PG synthesis 
(Ruiz 2008). Therefore, to further understand the function of murJBc in B. cenocepacia PG 
synthesis, we determined the level of accumulation of PG cell wall precursors under rhamnose 
depletion in a Prha::murJBc derivative carrying a lysA (BCAM 2076) deletion (strain YFM2, Table 
II). To achieve this, we radiolabeled lipid II with [3H]-DAP, which is incorporated into the MurNAc 
pentapeptide chain. We tested the cellular distribution of [3H]-DAP into the mature PG from 
equivalent amount of cells under permissive and non-permissive conditions. Using ascending 
paper chromatography we observed that rhamnose-depleted bacterial cells labeled with [3H]-
DAP accumulated a radioactive species with an average Rf value of 0.47 (Fig. 7A). Also, the 
amount of incorporation of the radioactive label under the non-permissive condition decreased 
to half as compared to the permissive condition. Lipids were extracted from the conditional 
mutant cells after labeling under permissive and the non-permissive conditions with a modified 
Bligh and Dyer 2 phase system (Guan, et al. 2005). Depending on the selective solubility of lipid 
II at different pH value, this molecule partitions in the aqueous phase at neutral pH and in the 
organic phase at acidic pH (Guan, et al. 2005). Our results showed a higher level of [3H]-DAP 
accumulation in the aqueous phase at neutral pH for the cell extracts under non-permissive 
conditions in comparison to the level of [3H]-DAP in the presence of rhamnose (2.25 ± 0.45 
ratio) as shown in Fig. 7B. Separation of the aqueous phase by ascending chromatography 
revealed peaks of [3H]-DAP accumulation at comparable Rf value as obtained before from 
ascending chromatography of the cell pellets (Fig. 7A). The peptidoglycan is expected to remain 
at the origin in the paper chromatography and the lipid precursors migrate to a further distance 
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by the effect of the lipophilic solvent. Ruiz showed that the nucleotide and lipid precursors 
accumulated in MurJ-depleted mutant in E. coli at Rf values of 0.25-0.35 and 0.8-0.9 
respectively (Ruiz 2008). However, it was reported that a mixture of lipid I and lipid II could 
migrate to an Rf value of 0.6 in E. coli (El Ghachi, et al. 2006). We confirmed the identity of lipid 
II by MS analysis using MALDI-TOF with negative ion mode and comparing the Mass spectra of 
lipid II from E. coli W3110 and B. cenocepacia K56-2 (Fig. 7C and D). The lipid II from E. coli 
showed two prominent peaks at m/z 956.39 and 925.4 (monoisotopic peaks) (Fig. 7C), which 
are very similar to those previously reported (Guan, et al. 2005). These peaks correspond to 
molecular weights of 1919 and 1851 that match the expected masses of lipid II with 11 and 10 
isoprene units, respectively (Guan, et al. 2005). The B. cenocepacia lipid II preparation also 
revealed two peaks in the region of the spectrum expected for lipid II (Fig. 7D). The 956.39 peak 
of the B. cenocepacia lipid II was identical to the corresponding peak of the E. coli lipid II (Fig. 
7C). However, the B. cenocepacia lipid II had a novel peak at m/z value of 933.29 (Fig. 7D). 
Compared to the corresponding peak in E. coli lipid II, the difference in m/z value indicates a 
difference in molecular weight of about 15.78, which could correspond to either an extra methyl 
or amino group in lipid II of B. cenocepacia. The nature of this difference will be investigated in a 
separate study, but it can account for a change that can also be reflected as a difference in the 
lipid II migration by paper chromatography and hence a different Rf value than that reported for 
E. coli (Ruiz 2008). 
 
MurJ proteins from B. cenocepacia and E. coli share a similar predicted fold and critical amino 
acid residues 
In a recent study (Butler, et al. 2013), a structural model of MurJEc was proposed predicting a 
central, solvent-exposed cavity containing charged residues that are essential for function. 
Essential amino acid residues in the central cavity of MurJEc were identified by a combination of 
cysteine and alanine replacements (Butler, et al. 2013). This work demonstrated that the 
charged residues located in trans-membrane helix 1 (R18 and R24), periplasmic loop 1 (D39), 
trans-membrane helix 2 (R52), and trans-membrane helix (R270) of MurJEc are accessible from 
the periplasmic space and required for function, as determined by complementation (Butler, et 
al. 2013). By CLUSTAL analysis, MurJ from E. coli and B. cenocepacia share 50% similarity 
(data not shown). As with the E. coli homologue, an in silico structural model of MurJBc was 
generated by I-Tasser (Roy, et al. 2010, Zhang 2008), and the resulting 3D structure was 
aligned to that of MurJEc. Both structures were nearly superimposable at most positions (Fig. 
8A) and display a characteristic central cavity exposed to the periplasmic space (Fig. 8B). The 
alignment of the 3D predicted models for the E. coli and B. cenocepacia MurJ proteins revealed 
that the MurJBc residues R18, R24, D39, and R52 are localized in the same regions as the 
corresponding residues in MurJEc, while MurJBc R274 corresponds to MurJEc R270 (Fig. 8C). 
MurJBc derivatives containing alanine replacements of these residues were constructed and 
tested for their ability to restore the viability of the Prha::murJBc mutant under non-permissive 
conditions. Alanine replacement of R18, R24, and R274 in MurJBc rendered the protein not 
functional while the replacements in D39 and R52 did not compromise function (Fig. 9A and B). 
These results were not due to lack of protein expression, as all the mutant proteins were 
expressed at similar levels as the parental MurJBc (Fig. 9C). In MurJEc, the D39 residue was also 
not required for function although it might be required only for structural stability (Butler, et al. 
2013), which could explain why the alanine replacement of the MurJBc D39 did not impair 
function. Another difference between the E. coli and B. cenocepacia MurJ proteins is that MurJEc 
completely loses function when R52 is replaced by cysteine, and has a partial defect when 
replaced by alanine (Butler, et al. 2013). Remarkably, the structural alignment of the predicted 
MurJBc and MurJEc structures also revealed that the side chains of the residues investigated by 
alanine replacement mutagenesis were also superimposable spatially, except for R270 and 
R274. These differences could be attributed to the nature of the modeling approach that is not 
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based on raw structural data but rather from an in silico approach. Regardless, both R270 and 
R274 were located at the same site and face of the predicted α-helix in both models and were 
also required for function. Together, these results show that despite some differences MurJBc 
and MurJEc belong to the same family of putative lipid II flippases. 
 
Concluding remarks 
The role of MurJ as the lipid II flippase has been disputed in part due to the reported absence of 
a lethal phenotype of a B. subtilis quadruple mutant in the murJ homologues ytgP, spoVB, ykvU, 
and yabM (Fay and Dworkin 2009, Vasudevan, et al. 2009). However, B. subtilis has two other 
genes, epsK and tuaB, which encode membrane proteins that share homologies with 
MurJ/MVIN/Wzx/Rft1 PFAM motifs (data not shown). Although EpsK and TuaB are respectively 
required for the synthesis of extracellular matrix and teichuronic acid, it may also be possible 
that any of these proteins provides functional redundancy involving lipid II flipping. This is 
conceivable, taking into account that the related Wzx family flippases, which are involved in the 
export of lipid linked O-antigen intermediates, have relaxed specificity for their substrates 
(Alaimo, et al. 2006, Feldman, et al. 1999, Marolda, et al. 2004). In our study, we demonstrate 
that the murJ homologue in B. cenocepacia K56-2 is indispensable for viability. A viable mutant 
in this gene could only be obtained using a conditional expression system. Under non-
permissive conditions the mutant rapidly ceased growing and individual bacterial cells lost their 
bacillary shape and showed indications of osmotic fragility, suggesting a cell wall defect. 
Biochemically, the mutant accumulates radiolabelled PG intermediates, which is consistent with 
the flipping function attributed to this family of proteins. We also demonstrated that MurJ 
proteins from both B. cenocepacia and E. coli are functional homologues since each of these 
proteins could restore viability in conditional mutant strains of both species. Furthermore, 
despite being only 50% related in their primary amino acid sequencing, the E. coli and B. 
cenocepacia MurJ proteins afforded similar predicted three-dimensional structures that were 
virtually superimposable including the predicted spatial location of residues that are critical for 
function. Therefore, our results with B. cenocepacia MurJ bring additional support to the notion 
that MurJ functions as lipid II flippase, as initially proposed for E. coli (Inoue, et al. 2008, Ruiz 
2008). 
 
Materials and methods 
 
Bacterial strains and growth conditions 
Strains and plasmids used in this study are listed in Table I. Bacteria were grown at 37°C in 
Luria-Bertani (LB) medium, SOB medium (2% tryptone, 0.5% yeast extract, 0.05% sodium 
chloride, 0.24% magnesium sulphate, 0.0186% potassium chloride) or M9 minimal medium, as 
required. Antibiotics were added to reach final concentrations as follows: 50 µg trimethoprim ml-
1 for E. coli and 100 µg ml-1 for B. cenocepacia, and 40 µg kanamycin ml-1 for E. coli. Ampicillin 
at 200 µg ml-1 and polymyxin at 20 µg ml-1 were used for triparental mating to select against 
donor and helper E. coli strains. Rhamnose and glucose were added to final concentrations of 
0.2% (W/V) as needed. Antibiotics and chemicals were purchased from Sigma Chemical (St. 
Louis, MO, USA). 
 
Recombinant DNA methods 
The primers used in this study are listed in Table II. The construction of pSC200 was previously 
reported (Cardona and Valvano 2005). DNA ligations, restriction endonuclease digestions, and 
agarose gel electrophoresis were performed according to standard techniques (Sambrook 
1990). Restriction enzymes, T4 DNA polymerase, and T4 DNA ligase were purchased from 
Roche Diagnostics, Dorval, Quebec, Canada. PCR amplifications were carried out using the 
HotStar HiFidelity polymerase (Qiagen). Colony-PCR was performed with Taq polymerase 
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(Qiagen). Amplifications were done according to the manufacturer's instructions and optimized 
for each primer pair. DNA sequencing was performed at the sequencing facility in York 
University (Toronto, Canada). 
 
Construction of a murJBc conditional mutant  
A 300-bp fragment of the upstream region of the murJBc gene (BCAL2764) was amplified using 
primers 6122 and 6123 and the amplicon cloned into pSC200 behind the plasmid-borne 
rhamnose promoter. Transformation of the ligation mixture was carried out in E. coli GT115 
competent cells by the calcium chloride method (Cohen, et al. 1972). Transformants were 
selected on LB agar plates containing 50 µg trimethoprim ml-1. Resistant colonies were 
screened by colony-PCR. Mobilization of plasmids into B. cenocepacia was conducted by 
triparental mating (Craig, et al. 1989) using the pRK2013 helper plasmid (Figurski and Helinski 
1979) on SOB plates containing 0.2% (W/V) rhamnose. Exconjugants were then isolated by 
plating on LB agar plates supplemented with 100 µg trimethoprim ml-1, 200 µg ampicillin ml-1, 20 
µg polymyxin ml-1 and 0.2% rhamnose (Ortega, et al. 2007). This experiment resulted in the 
isolation of the conditional mutant strain YFM1 (Prha::murJBc), in which the murJ gene is only 
expressed in the presence of rhamnose (see Results and Discussion). 
 
Complementation experiments 
A plasmid constitutively expressing MurJBc was constructed by amplifying the gene with primers 
6491 and 6388. Amplicons were digested with NdeI-XbaI and cloned into a similarly digested 
pDA12, resulting in pDA12-murJBc. We also constructed another plasmid, pEXT21-murJBc, in 
which murJ gene expression was placed under the control of the lac promoter using the primers 
Q369 and 6388. The murJ homologue from E. coli K-12 was amplified with primers 6578 and 
6579 and also cloned into pDA12. For complementation in B. cenocepacia, pDA12-murJBc or 
pDA12-murJEc were introduced into the conditional mutant strain YFM1 by triparental mating as 
described above. For complementation in E. coli, pDA12-murJBc was introduced by 
electroporation into the E. coli mutant NR1152 (Para::murJEc) (Ruiz 2008) and transformants 
selected on 25 µg ampicillin ml-1, 30 µg tetracycline ml-1 and arabinose 0.2%. Also, pEXT21-
murJBc was introduced by electroporation into NR1152 and selection was made on plates 
containing 80 µg spectinomycin ml-1. For induction of MurJBc expression, an overnight culture of 
NR1152 (pEXT21-murJBc) was diluted to OD600 of 0.2 in the presence of the appropriate 
antibiotics, incubated at 37ºC for 2 h up to an OD600 of 0.6 at which time IPTG (Isopropyl β-D-1-
thiogalactopyranoside) was added to final concentration of 0.1 mM, and the culture was 
incubated for further 3 h. 
 
Conditional viability by rhamnose depletion 
The conditional viability of mutant YFM1 (Prha::murJBc) was assessed after an overnight growth 
at 37°C in M9 minimal medium supplemented with 0.5% yeast extract, 1 µM CaCl2, 1 µM 
MgSO4, 0.2% rhamnose, and 100 µg trimethoprim ml-1. An aliquot of the overnight culture was 
centrifuged and the bacterial pellet was washed three times with sterile phosphate-buffered 
saline (PBS), resuspended in PBS, and adjusted to OD600 of 1. Ten 10 µl-drops of the undiluted 
suspension and 10−1, 10−2, 10−3, and 10−4 dilutions were deposited onto M9 agar plates 
supplemented with 0.2% glucose or 0.2% rhamnose and incubated at 37°C for 24 h. The same 
procedure was done to test the complementation of NR1152 by murJBc except that the M9 agar 
plates were supplemented with either 0.2% arabinose or 0.05% fucose (Ruiz 2008). The 
essentiality of murJBc was further demonstrated by monitoring growth in liquid medium in a 
rhamnose depletion assay (Ortega, et al. 2007). Washed, rhamnose-depleted cells were diluted 
to an OD600 of 0.15 in M9 medium supplemented with 0.5% yeast extract and 0.2% glucose, and 
incubated at 37°C for 4 h with shaking. Growing cells were aliquoted to 100-well plates 
containing fresh medium with 0.2% glucose to give an OD600 of 0.05 and monitored for growth 
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for additional 12 h in a Bioscreen C automated growth curve reader (MTX Lab Systems, Inc., 
Vienna, VA) at 37 °C with constant, low shaking with OD600 readings taken every 30 min. 
Microscopy 
Samples of depleted cultures grown in the absence of rhamnose were taken after 6 h, placed on 
0.8% agarose slides, covered by a coverslip and examined by phase-contrast microscopy. 
Other samples from the same cells were fluorescently stained with Syto 9 and propidium iodide 
(LIVE/DEAD BacLight bacterial viability kit; Molecular Probes, Invitrogen Detection 
Technologies, Eugene, OR). Samples were also examined by electron microscopy after fixing 
with 2.5% glutaraldehyde and staining with 2% uranyl acetate and lead citrate, as previously 
described (Schmerk, et al. 2011). Grids were visualized with a Philips 410 transmission electron 
microscope at 60 kV. 
 
Killing curves using β-lactam antibiotics and E-tests 
Washed rhamnose-depleted cells were diluted to an OD600 of 0.15 in M9 minimal medium 
supplemented with either 0.2% or 0.05% rhamnose and allowed to grow for 4 h. Then, cultures 
were diluted to approximately 2x105 cfu ml-1 in M9 minimal media and dispensed in 100-well 
plates in 300 µl volumes. Either ceftazidime, imipenem or chloramphenicol were previously 
added to the 100-well plate to give final concentrations ranging from 2 to 128 µg ml-1 in two fold 
increments. Plates were incubated in a Bioscreen C automated growth curve reader for 24 h 
with OD600 readings taken every 30 min. For E-tests, depleted cells were washed and the OD600 
adjusted to 0.5 McFarland opacity standard. A sterile cotton swab was dipped into the bacterial 
suspension and streaked all over the surface of the Müller-Hinton agar plates in three directions 
to obtain an even distribution of the inoculum. The E-test strips (BioMérieux Clinical 
Diagnostics) for ceftazidime and imipenem were deposited onto the inoculated plates by means 
of a sterile forceps and the plates were incubated at 37ºC for 48 h. 
 
Detection of cytoplasmic content leakage using anti-RNA polymerase antibody  
Rhamnose-depleted liquid cultures were prepared as described above. One-ml volumes of 
cultures at an OD600 of 1 were centrifuged for 1 min at 13 000 xg; cells were resuspended in 20 
µl distilled water and 10 µl of 3x loading dye, and boiled for 5 min to prepare whole cell lysates. 
To examine the culture supernatants, 35 ml of depleted culture was centrifuged for 15 min at 
7000 xg at 4°C. Supernatant was collected, filter-sterilized and proteins were precipitated 
overnight at 4°C in 10% trichloroacetic acid and protease inhibitor. Then, the mixture was 
centrifuged at 10 000 xg for 30 min at 4°C. The pellet was washed with 5 ml acetone and 
centrifuged for another 30 min. Acetone was removed and pellet was suspended in 150 µl 
sodium phosphate buffer 0.1 M pH 7. The resulting suspension was boiled for 5 min. Five µl-
aliquots of boiled samples for both the whole cell lysate and the supernatant were separated by 
gel electrophoresis using 14 % (w/v) SDS-polyacrylamide gels and transferred to a 
nitrocellulose membrane. The membrane was rinsed with Tris-buffered saline, pH 8 (TBS) and 
then blocked overnight with 10 % (v/v) Western blocking reagent (Roche) in TBS at 4°C. The 
membrane was then incubated with monoclonal antibody to E. coli RNA-polymerase α-subunit 
(Neoclone) diluted 1:10 000 for 1.5 h at room temperature. The membrane was washed with 
TBS and then incubated at room temperature for 20 min with anti-mouse IgG antibody 
conjugated to Alexa Fluor 680 (Molecular Probes) diluted 1:20 000. Proteins were visualized 
using a Licor Infrared Imaging System with Odyssey software version. A separate gel was also 
prepared for Coomassie blue staining. 
 
Detection of accumulation of peptidoglycan precursors using [3H]-DAP 
To increase the incorporation of [3H]-diaminopimelic acid (DAP) into growing cells, we 
constructed a strain with a lysA (BCAM2076) deletion using the method of Flannagan et al. 
(Flannagan, et al. 2008) for the construction of unmarked, non-polar deletions in B. 
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cenocepacia. lysA is responsible for decarboxylation of DAP into lysine, and its deletion would 
result in the direct incorporation of exogenously added DAP to the PG (Wientjes, et al. 1985). A 
murJ conditional mutant was constructed in the ∆lysA background strain. The resulting strain, 
YFM2 (Prha::murJ ∆lysA), was grown overnight in M9 minimal medium containing rhamnose and 
100 µg trimethoprim ml-1. Cells were washed as indicated above, diluted 1:100 fold into fresh 
M9 minimal medium containing glucose, methionine, lysine, and threonine and grown under 
aeration at 37°C for 4 h to OD600 of 0.6 (approximately four generations). Cells were diluted to 
an OD600 of 0.1 in fresh medium containing glucose, methionine, lysine, and threonine and 
labeled for 2 h at 37°C with 5 µCi of [3H]-DAP (30 Ci/mmol; American Radiolabeled Chemicals) 
(Wientjes, et al. 1985). After 2 h, the cells were exposed again to 5 µCi of [3H]-DAP for another 
2 h. At the end of the labeling period, cells were placed on ice and pelleted at 4°C for 5 min at 
13 000 xg. Pellets were resuspended in 10 µl of ice-cold water and immediately frozen until they 
were subjected to paper chromatography (Ramey and Ishiguro 1978, Ruiz 2008). Labeled cells 
were spotted onto Whatman 3MM paper (57x49 cm), and labeled peptidoglycan precursors 
were separated by ascending chromatography by development with isobutyric acid:1M 
NH4OH(5:3; vol/vol) for 36 h. Paper was dried and cut into 1-cm squares that were counted in 
vials containing scintillation mixture (Ready Safe; Beckman Coulter). 
  
Lipid II extraction of radiolabeled cells 
Labeled cells prepared as mentioned above were resuspended in 100 µl of PBS (pH 7.4), 
followed by the addition of 125 µl of chloroform and 250 µl of methanol. After periodic Vortex 
mixing for 10 min at room temperature, the homogenates were centrifuged at 4 000 xg for 10 
min and then the supernatants were converted to a two phase Bligh-Dyer system by adding 125 
µl chloroform and 125 µl PBS (Bligh and Dyer 1959, Guan, et al. 2005). Since Lipid II partitions 
into the upper aqueous phase of a two-phase Bligh–Dyer system at the neutral pH of PBS, this 
aqueous layer was separated and counted in vials containing scintillation mixture (Bligh and 
Dyer 1959, Guan, et al. 2005). To confirm the presence of [3H]-DAP labelled lipid II in the 
aqueous phase, this layer was also spotted onto Whatman 3MM paper for separation of lipid II 
by ascending chromatography. The identity of lipid II was confirmed by mass spectrometry (MS) 
analysis using matrix-assisted laser desoprtion/ionization-time of flight (MALDI-TOF). Lipid II 
was extracted as previously described (Guan, et al. 2005) and dissolved in 100 µl of 
chloroform/methanol (2:1, v/v). One µl of this mixture was loaded on the target and covered by 1 
µl of the 5-chloro-2-mercaptobenzothiazole (20mg/ml) matrix. The target was inserted in a 
Bruker Autoflex MALDI-TOF spectrometer. Data acquisition and analysis were performed using 
the Flex Analysis software. 
 
Site directed mutagenesis 
murJBc was PCR amplified from genomic B. Cenocepacia using the primers Q294 (introducing a 
Flag-tag at the N-terminal) and 6388. The PCR product was cut with NdeI and XbaI and ligated 
to pDA12 cut with the same restriction enzymes to create pYM29 (pDA12-FLAGmurJBc), which is 
used as a template. Five point mutations were created individually in pDA12-FLAGmurJBc as 
previously described (Hamad, et al. 2012). Complementary primers were designed to contain 
the desired mutation (Ala), flanked by unmodified sequence to anneal to the same sequence on 
opposite strands of the template plasmid.  Primers from Q295 to Q304 (Table 2) were used in 
pairs to create Ala point mutations in 5 selected residues which are R18, R24, D39, R52 and 
R274 that correspond to similar residues in the E. coli murJ (Butler, et al. 2013) to create the 
plasmids pYM31-pYM35 respectively.  The plasmids were introduced into the strain YFM1 
(Prha::murJBc) by triparental mating and tested for their ability to complement YFM1 under non-
permissive conditions. MurJ protein expression was detected on total membranes that were 
prepared as described before (Patel, et al. 2012) with the only modification that the overnight 
culture was diluted to OD600 of 0.2 then incubated at 37◦C to grow for about 6 h to reach OD600 
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of 0.8-1. Protein concentration was measured using a nanodrop (Nanovue Plus, GE 
Healthcare). Flag-tagged MurJ was revealed by immunoblotting using a 1:10,000 dilution of the 
mouse anti-Flag monoclonal antibody. Proteins were visualized using a Licor Infrared Imaging 
System with Odyssey software version. 
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Table I: Bacterial strains and plasmids	  
Strain or         Characteristics                  Source or 
Plasmid                        Reference 
E. coli 
DH5α   F- ɸ 80 lacZ∆M15 endA1 recA1 hsdR17(r-Km+K) supE44 thi-1           Invitrogen 
    ∆gyrA96 (∆lacZYA-argF)U169 relA1 
GT115   F- mcrA ∆(mrr-hsdRMS-mcrBC) ɸ 80lacZ∆M15 ∆lacX74               Lab stock  
    recA1 rpsL endA1 ∆dcm uidA(∆MluI)::pir-116 ∆sbcC-sbcD       
NR1152   NR754; araD+ revertant of MC4100; murJΩ (-14::bla araC PBAD       (Ruiz 2008) 
W3110   IN (rrnD-rrnE)1 rph-1                             Lab Stock 
 
B. cenocepacia 
K56-2   Clinical isolate, ET12 clone related to J2315            BCRRC 
YFM1   K56-2; Prha::murJBc (BCAL2764); TpR            This study 
YFM2   YFM11; Prha::murJBc (BCAL2764); TpR            This study 
YFM11   K56-2; ∆lysA (BCAM2076)               This study 
XOA10   K56-2; Prha::BCAL1928                (Ortega, et al. 2007) 
XOA11   K56-2; Prha::arnT (BCAL1929)              (Ortega, et al. 2007) 
 
Plasmids 
pDA12   Cloning vector, oripBBR1, TetR, mob+, Pdhfr               (Aubert, et al. 2008) 
pDAI-SceI-SacB oripBBR1, TetR, Pdhfr, mob+, sacB+,              (Hamad, et al. 2010) 
pEXT21   Low copy number cloning vector, oriIncW-pSF6, SpR, Ptac            (Dykxhoorn, et al. 1996) 
pGPISce-I  oriR6K, mob+, ΩTpR , ISce-I restriction site           (Flannagan, et al. 2008) 
pRK2013  oricolE1, RK2 derivative, KanR, mob+, tra+                        (Figurski and Helinski 1979) 
pSC200   Cloning vector, oripBBR1 rhaR, rhaS, PrhaB, TpR           (Cardona and Valvano 2005) 
pYM1   pSC200-murJBc                        This study 
pYM3   pGPI-SceI with fragments flanking BCAM2076                This study 
pYM21   pDA12-murJEc, TetR                   This study 
pYM28   pDA12-murJBc, TetR                   This study 
pYM29   pDA12-FLAGmurJBc, N-terminal FLAG-Tag, TetR             This study 
pYM30   pEXT21-FLAGmurJBc, N-terminal FLAG-Tag, SpR          This study 
pYM31   pDA12-FLAGmurJBc-R18A, N-terminal FLAG-Tag, TetR         This study 
pYM32   pDA12-FLAGmurJBc-R24A, N-terminal FLAG-Tag, TetR         This study 
pYM33   pDA12-FLAGmurJBc-D39A, N-terminal FLAG-Tag, TetR               This study 
pYM34   pDA12-FLAGmurJBc-R52A, N-terminal FLAG-Tag, TetR         This study 
pYM35   pDA12-FLAGmurJBc-R274A, N-terminal FLAG-Tag, TetR              This study 
aTpR, trimethoprim resistance, TetR, tetracycline resistance, KanR  , kanamycin resistance, SpR, 
spectinomycin resistance.  
bBCRRC, B. cepacia Research and Referral Repository for Canadian CF Clinics. 
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Table II: Primers 
 
Primer 
number 
 
Oligonucleotide sequence, 5'–3' 
 
Restriction 
enzyme 
6122 
6123 
6290 
6291 
6347 
6348 
6491 
6388 
6578 
6579 
Q294 
Q369 
Q295 
Q296 
Q297 
Q298 
Q299 
Q300 
Q301 
Q302 
Q303 
Q304 
AAAAAACATATGAATCTATTCCGAGCCCTGCT 
AAAAAATCTAGATCTTGAACTCGGCGAGGAT 
AAAACTCGAGGACGTTCGAATTCGCCTTCT 
AAAACTCGAGGCGTCGATGTCGTCGAACTA 
AAAATCTAGACGTTCGAGCCCCACATAC 
AAAAGAATTCGTTCTTCGGCCTCCTGCT 
TTTTTTCATATGGCGCAACGTCCGTATAATAA 
TTTTTCTAGATCACTTGGCGCGCCTT 
GATCGATCATATGAATTTATTAAAATCGCTGGCCGCCGTCAGCTCG 
CCGCACTCTAGATTACACCGTCCGGCGGGCAAATTCTTTAACTTTG 
TTTTTTCATATGgactacaaggacgacgacgacgacaagGCGCAACGTCCGTATAATAA 
TTTTTTGAATTCgactacaaggacgacgacgacgacaagGCGCAACGTCCGTATAATAA 
TTCACGCTGCTGTCGGCGGTGACCGGACTGGCC 
GGCCAGTCCGGTCACCGCCGACAGCAGCGTGAA 
GTGACCGGACTGGCCGCGGAGACGCTGATCGCC 
GGCGATCAGCGTCTCCGCGGCCAGTCCGGTCAC 
CCAGTCAATACACCGCGGCGTTCTACGTCGCC 
GGCGACGTAGAACGCCGCGGTGTATTGACTGG 
ATTCCGAACCTGCTGGCGCGCCTGTCTGCCGAA 
TTCGGCAGACAGGCGCGCCAGCAGGTTCGGAAT 
ATCAATTACGCCGACGCGCTGATGGAGTTCCCG 
CGGGAACTCCATCAGCGCGTCGGCGTAATTGAT 
NdeI 
XbaI 
XhoI 
XhoI 
XbaI 
EcoRI 
NdeI 
XbaI 
NdeI 
XbaI 
NdeI 
EcoRI 
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Table III: MIC of Ceftazidime and Imipenem 
 
Antibiotic 
MIC (µg/ml) 
Rhamnose 0.2% Rhamnose 0.05% 
YFM1 XOA10 YFM1 XOA10 
Ceftazidime 0.75 0.75 0.125 0.75 
Imipenem > 32 > 32 1 > 32 
Chloramphenicol 32 32 32 32 
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Figure Legends 
FIG. 1. A. Conditional lethal phenotype of strain YFM1 (Prha::murJBc) on LB agar plates 
supplemented with 0.2% rhamnose or 0.2% glucose. XOA10 (Prha::BCAL1928) and XOA11 
(Prha::arnT) are rhamnose-independent and -dependent control mutants (Ortega, et al. 2007). B. 
Complementation of YFM1 (Prha::murJBc) with pDA12-BCAL2764 (MurJBc) and pDA12-murJEc 
compared to vector control in the presence and absence of rhamnose. C. Complementation of 
E. coli NR1152 (Para::murJEc) with pEXT21-murJBc and pDA12-murJBc compared to the 
corresponding vector controls in the presence and absence of arabinose. 
 
Fig. 2. Depletion experiment in liquid medium using YFM1 (Prha::murJBc), and the control strains 
XOA10 (Prha::BCAL1928) and XOA11 (Prha::arnT) (Ortega, et al. 2007). The solid symbols 
indicate the permissive condition while the empty ones correspond to the non-permissive 
condition. Growth was monitored every hour using a Bioscreen system. The figure is 
representative of three independent biological repeats with similar results. Bars indicate the 
standard errors of triplicate observations at each time point. 
 
Fig. 3. Phase contrast microscopy of YFM1 (Prha::murJBc) bacteria at 6-h following growth under 
permissive (0.2% rhamnose) and non-permissive (0.2% glucose) conditions using oil-immersion 
objective lens in a Zeiss Axioscope II microscope (Magnification: 1,000 X). Arrows indicate 
ghost cells. 
 
Fig. 4. Transmission electron microscopy of YFM1 (Prha::murJBc) bacteria under permissive (A, 
B) and non-permissive (C, D, E, F) conditions. Bars, 0.5 µm. 
 
Fig. 5. Live-Dead staining of YFM1 (Prha::murJBc) under permissive (0.2% rhamnose) and non-
permissive (0.2 % glucose) conditions compared to rhamnose-independent control strain 
XOA10 (Prha::BCAL1928). Live bacteria appear fluorescent green, while dead bacteria and 
bacteria with compromised membranes appear fluorescent red. Arrow indicates a red-
fluorescent mesh consistent with extracellular DNA. 
 
Fig. 6. Loss of cell membrane integrity by determining release of cytoplasmic content to the 
culture supernatant. Whole cell lysates and culture supernatants of YFM1 (Prha::murJBc) and the 
control strain XOA10 (Prha::BCAL1928) where prepared as described in Material and Methods 
after 6 h of growth in non-permissive (Lanes 1, 2, 4, and 5) and -permissive (lanes 3 and 6) 
conditions (Lanes 3 and 6). 10-15 ng of protein were loaded in each lane. A. Coomassie blue 
staining. B. Western blot developed using anti-RNA polymerase antibodies. Only the section of 
the blot with the detected protein bands is shown. The arrow indicates the presence of α subunit 
of the RNA polymerase (α-RNAP). M, Precision Plus™ Dual Color Protein Standards (a mixture 
of 10 recombinant proteins of 250, 150, 100, 75, 50, 37, 25, 20, 15, 10 kDa). 
 
Fig. 7. Characterization of lipid II in B. cenocepacia.  A. Ascending paper chromatography of 
cell pellets of the strain YFM2 (Prha::murJBc, ∆lysA) under permissive (rhamnose) and non-
permissive (glucose) conditions showing accumulation of cell wall precursors under the non-
permissive condition. This experiment is a representative of 3 independent experiments 
showing accumulation of lipid II at average Rf value of 0.47. B. Accumulation of extracted lipid II 
from aqueous phase of the strain YFM2 under the non-permissive condition. Data correspond to 
the average of CPM ± standard deviation of 3 independent experiments. n=3. Pvalue= 0.0247. 
C. MALDI-TOF MS of lipid II of E. coli W3110. D. MALDI-TOF MS of lipid II of B. cenocepacia 
K56-2. C and D are representative spectra of 3 independent preparations of lipid II. 
 
Fig. 8. Structural model of MurJ proteins from B. cenocepacia (gray) and E. coli (pink). A. Front 
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view; B. top view from the periplasmic side; C. position of conserved functional residues.  
 
Fig. 9. Growth of YFM1 (Prha::murJBc) using MurJBc and its derivatives carrying alanine 
replacements in the following charged residues: arginine-18 (R18A), arginine-24 (R42A), 
aspartic acid-39 (D39A), arginine-52 (R52A), and arginine-274 (R274A). Bacteria were grown 
under permissive (panel A) and non-permissive conditions (panel B). C. Western blot 
demonstrating that all MurJBc parental and mutant derivatives (expressed as N-terminal FLAG 
fusions) are correctly expressed (arrow) in the (Prha::murJBc) strain background. M, molecular 
mass ladder.  
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